综合基因组分析和CRISPRi涉及EGFR在阿尔茨海默病的风险
Yuk Yee Leung1, Pavel P Kuksa1, Luke Carter1
1Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA.
medRxiv : the preprint server for health sciences
|July 16, 2025
概括
这项研究确定了一种微质增强剂,可以调节晚发性阿尔茨海默病 (LOAD) 中的EGFR表达. 这一发现表明EGFR抑制剂是LOAD的潜在治疗策略.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了与晚发性阿尔茨海默病 (LOAD) 相关的众多位点.
- 这些与LOAD相关的位点对特定的大脑区域的特定影响尚不清楚.
- 功能性基因组学数据对于了解遗传变异对疾病风险的影响至关重要.
研究的目的:
- 使用功能基因组学数据系统地分析与LOAD相关的区域.
- 在大脑中识别候选因果变异及其效应基因.
- 调查 LOAD遗传风险背后的监管机制.
主要方法:
- 在174个数据集中利用了FILER功能基因组学目录.
- 分析了增强剂,转录因子和定量特征位点 (QTL).
- 采用增强剂-促进剂相互作用数据,变异注释和细胞类型特定的基因表达分析.
- 通过微质中以促进体为重点的Capture C,ATAC-seq和CRISPR干扰进行功能验证.
主要成果:
- 确定了42个候选因果变异效应因子基因对.
- 预计在SEC61G位点的LOAD风险基因rss74504435会增加LOAD相关的大脑细胞类型 (小质细胞,星体细胞,神经元) 中的EGFR表达.
- 证实了微质增强剂与人类微质 (HMC3细胞系) 中EGFR表达之间的调控关系.
结论:
- 一种微质增强剂在调节EGFR表达方面发挥作用,在LOAD的背景下.
- EGFR信号传递与LOAD病原发生有关.
- EGFR抑制剂代表了治疗晚发性阿尔茨海默病的潜在治疗途径.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.1K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.9K
相关概念视频
01:26Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
01:11Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K